Yeah, so the Decipher is already, I would say, a standard approach to try and give us information whether we should intensify therapy or de-intensify therapy. And here we see that also in non-American patients, the test performs well, and we should consider doing the test also in these patients. Regarding the transcriptomic profile differences, this is just a hypothesis-generating and down the road it should be validated also in larger cohorts before we can conclude any definitive conclusions...
Yeah, so the Decipher is already, I would say, a standard approach to try and give us information whether we should intensify therapy or de-intensify therapy. And here we see that also in non-American patients, the test performs well, and we should consider doing the test also in these patients. Regarding the transcriptomic profile differences, this is just a hypothesis-generating and down the road it should be validated also in larger cohorts before we can conclude any definitive conclusions.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
